Expression of SIY and HEL antigens on reisolated tumors
| Inoculation on side A | Inoculation on side B | Animal number | Tumor on side B | |||
| Days of growth | Volume | Antigen expression (% of tumor cells positive) | ||||
| SIY only | HEL only | |||||
| mm3 | % | % | ||||
| Experiment I | ||||||
| A-SIY/HEL | A-SIY + A-HEL | 1 | 21 | 2,600 | <1 | 93 |
| A-SIY/HEL | A-SIY + A-HEL | 2 | 21 | 1,950 | <1 | 96 |
| A-SIY/HEL | A-SIY + A-HEL | 3 | 21 | 4,900 | <1 | 89 |
| A-SIY/HEL | A-SIY + A-HEL | 4 | 21 | 2,600 | <1 | 95 |
| None | A-SIY + A-HEL | 1 | 18 | 1,300 | <1 | 94 |
| None | A-SIY + A-HEL | 2 | 18 | 1,200 | <1 | 95 |
| Experiment II | ||||||
| A-SIY/HEL | A-SIY | 1 | 26 | 520 | 80 | NA |
| A-SIY/HEL | A-SIY | 2 | 26 | 644 | 83 | NA |
| A-SIY/HEL | A-SIY | 3 | 29 | 520 | 82 | NA |
| Inoculation on side A | Inoculation on side B | Animal number | Tumor on side B | |||
| Days of growth | Volume | Antigen expression (% of tumor cells positive) | ||||
| SIY only | HEL only | |||||
| A-SIY/HEL | A-SIY + A-HEL | 1 | 21 | 2,600 | <1 | 93 |
| A-SIY/HEL | A-SIY + A-HEL | 2 | 21 | 1,950 | <1 | 96 |
| A-SIY/HEL | A-SIY + A-HEL | 3 | 21 | 4,900 | <1 | 89 |
| A-SIY/HEL | A-SIY + A-HEL | 4 | 21 | 2,600 | <1 | 95 |
| None | A-SIY + A-HEL | 1 | 18 | 1,300 | <1 | 94 |
| None | A-SIY + A-HEL | 2 | 18 | 1,200 | <1 | 95 |
| A-SIY/HEL | A-SIY | 1 | 26 | 520 | 80 | NA |
| A-SIY/HEL | A-SIY | 2 | 26 | 644 | 83 | NA |
| A-SIY/HEL | A-SIY | 3 | 29 | 520 | 82 | NA |
NA, not applicable. 5 × 105 A-SIY/HEL or A-SIY cancer cells or 2.5 × 105 A-SIY mixed with 2.5 × 105 A-HEL cancer cells were injected subcutaneously into opposite flanks of B6C3 mice as indicated. Tumor growth was monitored. Tumors on side B were readapted to culture and analyzed by flow cytometry for expression of the SIY and HEL antigens. Data are representative of at least two independent experiments.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.